Bionano Genomics, Inc. (BNGO)
NASDAQ: BNGO · Real-Time Price · USD
1.660
-0.030 (-1.78%)
At close: Sep 25, 2026, 4:00 PM EDT
1.612
-0.048 (-2.91%)
After-hours: Sep 25, 2026, 7:51 PM EDT
Bionano Genomics Revenue
Bionano Genomics had revenue of $-6.67M in the quarter ending June 30, 2026. This brings the company's revenue in the last twelve months to $15.33M, down -44.09% year-over-year. In the year 2025, Bionano Genomics had annual revenue of $28.51M, down -7.37%.
Revenue (ttm)
$15.33M
Revenue Growth
-44.09%
P/S Ratio
0.65
Revenue / Employee
$311,093
Employees
97
Market Cap
19.55M
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 28.51M | -2.27M | -7.37% |
| Dec 31, 2024 | 30.78M | -5.34M | -14.79% |
| Dec 31, 2023 | 36.12M | 8.31M | 29.90% |
| Dec 31, 2022 | 27.80M | 9.82M | 54.62% |
| Dec 31, 2021 | 17.98M | 9.48M | 111.47% |
| Dec 31, 2020 | 8.50M | -1.63M | -16.06% |
| Dec 31, 2019 | 10.13M | -1.87M | -15.59% |
| Dec 31, 2018 | 12.00M | 2.50M | 26.26% |
| Dec 31, 2017 | 9.51M | 2.71M | 39.93% |
| Dec 31, 2016 | 6.79M | - | - |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Related Stocks
| Company Name | Revenue |
|---|---|
| Harvard Bioscience | 87.81M |
| Retractable Technologies | 33.90M |
| Stereotaxis | 30.07M |
| Precision Optics Corporation | 28.94M |
| Nephros | 20.72M |
| Milestone Scientific | 9.42M |
| Lucyd | 3.41M |
| Femasys | 2.30M |
BNGO News
- 3 days ago - Bionano Laboratories Announces Expansion of Diagnostic Testing Based on Optical Genome Mapping for Hematologic Malignancies - GlobeNewsWire
- 12 days ago - Bionano Genomics Transcript: H.C. Wainwright 28th Annual Global Investment Conference - Transcripts
- 12 days ago - Bionano Announces Three New Peer-Reviewed Studies Demonstrate Clinical Value of Bionano's Optical Genome Mapping Across Myelodysplastic Syndromes and Acute Myeloid Leukemia - GlobeNewsWire
- 16 days ago - Bionano Laboratories Announces Proposed Local Coverage Determination (LCD) from MolDX for Genome-Wide Detection of Structural Variants in Hematologic Neoplasms - GlobeNewsWire
- 18 days ago - Bionano Laboratories Announces New York State Department of Health Approval of Lab Developed Tests Based on Optical Genome Mapping - GlobeNewsWire
- 4 weeks ago - Bionano to Participate in the H.C. Wainwright 28th Annual Global Investment Conference - GlobeNewsWire
- 6 weeks ago - Bionano Genomics Earnings Call Transcript: Q2 2026 - Transcripts
- 6 weeks ago - Bionano Genomics Earnings release: Q2 2026 - Filings